Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
Vaxcyte, Inc. (PCVX) had Earnings per Share (EPS) (Basic) of $-1.97 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-284.30M |
|
-- |
|
-- |
|
$302.78M |
|
$-302.78M |
|
$18.48M |
|
$-284.30M |
|
$-284.30M |
|
$-284.30M |
|
$-284.30M |
|
$-284.30M |
|
$-284.30M |
|
$-302.78M |
|
$-298.03M |
|
144.49M |
|
144.49M |
|
|
Earnings per Share (EPS) (Basic) |
$-1.97 |
$-1.97 |
|
| Balance Sheet Financials | |
$1.55B |
|
$260.39M |
|
$1.59B |
|
$3.14B |
|
$271.28M |
|
-- |
|
$108.94M |
|
$380.21M |
|
$2.76B |
|
$2.76B |
|
$2.76B |
|
144.79M |
|
| Cash Flow Statement Financials | |
$-513.10M |
|
$-85.69M |
|
$607.28M |
|
$175.43M |
|
$184.66M |
|
$9.23M |
|
$79.20M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.72 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-519.52M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-10.31% |
|
-10.31% |
|
-9.06% |
|
-10.31% |
|
$19.05 |
|
$-3.60 |
|
$-3.55 |
|